Skip to main content
Premium Trial:

Request an Annual Quote

Chinese, American Researchers Publish Cucumber Genetic Map

NEW YORK (GenomeWeb News) – In a paper appearing online today in PLoS ONE, researchers from China and the US reported that they have come up with an integrated genetic and cytogenetic map of cucumber.

Researchers from the Chinese Academy of Agricultural Sciences, the China Agricultural University, and the US Department of Agriculture's Agricultural Research Service used whole genome shotgun sequencing to come up with nearly 1,000 polymorphic simple sequence repeat markers in cucumber. Using these markers, along with cytogenetic data, they then created a high-density linkage map that's expected to form the foundation for future genetic and genomic studies in cucumbers and related plants.

"This map will facilitate whole genome sequencing, positional cloning, and molecular breeding in cucumber, and enable the integration of knowledge of gene and trait in cucurbits," senior author Sanwen Huang, a researcher at the Chinese Academy of Agricultural Sciences' Institute of Vegetables and Flowers, and his co-authors wrote.

Cucumbers belong to the family Cucurbitaceae, which contains about 800 species. Among them: other commercially important plants such as melon, watermelon, squash, and pumpkin.

Previous research suggests the cucumber genome — which is an estimated 367 million bases in size — is contained on seven different chromosomes. Although low density genetic linkage maps have been developed for cucumber over the years, Huang and his team noted that genetic resources are few and far between in the cucumber family.

To create a high-density linkage map of the cucumber genome, the researchers started by using whole genome Sanger shotgun sequencing to get about three times coverage of the cucumber genome. Based on their sequencing effort, the researchers selected 995 simple sequence repeat, or SSR, markers belonging to seven different linkage groups.

The team subsequently integrated data from these polymorphic SSR markers with results from fluorescence in situ hybridization to assign these linkage groups to seven cucumber chromosomes. They also identified 678 recombination breakpoints in the cucumber genome.

Using FISH, the team detected an inversion on chromosome 5 that differed between the cultivated cucumber variety C. sativus var. sativus and the C. sativus var. hardwickii variety, which is believed to represent the feral form of cucumber.

The researchers also detected roughly three times as many polymorphisms as expected between the North American strain Gy14 and the PI 183967, a C. sativus var. hardwickii strain from India.

"This result demonstrated the power of whole genome sequences in enhancing genetic analysis of an under-investigated crop with a narrow genetic base," the authors wrote. "In turn, the saturated genetic map will help anchor DNA sequence assemblies onto chromosomes to generate a map-based genome sequence of cucumber."

When the researchers compared SSR markers in eleven inbred cucumber lines and two lines each of melon, watermelon, and squash, they found that about 65 percent of the markers were polymorphic in the cucumber lines, suggesting they may by useful for following desirable cucumber traits and perhaps guiding crop improvement.

The researchers suggested that the newly identified SSR markers may also prove beneficial in other crops as well. Nearly half of the cucumber SSR markers — 49 percent — appear to be conserved in melon. About 26 percent of the 995 cucumber SSRs were conserved in watermelon and 22 percent were conserved in pumpkin.

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.